{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T09:47:17Z","timestamp":1776246437209,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T00:00:00Z","timestamp":1651104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T00:00:00Z","timestamp":1651104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003653","name":"Korea National Institute of Health","doi-asserted-by":"publisher","award":["HI18C0531"],"award-info":[{"award-number":["HI18C0531"]}],"id":[{"id":"10.13039\/501100003653","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2017M3A9B6061509"],"award-info":[{"award-number":["2017M3A9B6061509"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2018M3A9E8023861"],"award-info":[{"award-number":["2018M3A9E8023861"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2019R1C1C1004580"],"award-info":[{"award-number":["2019R1C1C1004580"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2019R1C1C1007366"],"award-info":[{"award-number":["2019R1C1C1007366"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Hepatocellular carcinoma (HCC) is one of the most common and lethal cancers worldwide. Wiskott\u2013Aldrich syndrome protein family member 2 (WASF2) is an integral member of the actin cytoskeleton pathway, which plays a crucial role in cell motility. In this study, we aimed to explore the role of <jats:italic>WASF2<\/jats:italic> in HCC carcinogenesis and its regulatory mechanism.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p><jats:italic>WASF2<\/jats:italic> expression in HCC was analyzed using six public RNA-seq datasets and 66 paired tissues from patients with HCC. The role of <jats:italic>WASF2<\/jats:italic> in normal hepatocyte cell phenotypes was evaluated using a <jats:italic>WASF2<\/jats:italic> overexpression vector in vitro; it was evaluated in HCC cell phenotypes using small interfering RNA (siRNA) in vitro and in vivo. Epigenetic regulatory mechanism of <jats:italic>WASF2<\/jats:italic> was assessed in the Cancer Genome Atlas liver hepatocellular carcinoma project (TCGA_LIHC) dataset and also validated in 38 paired HCC tissues. Site mutagenesis, bisulfite sequencing polymerase chain reaction (BSP), methylation-specific polymerase chain reaction (MSP), and quantitative MSP (qMSP) were used for evaluating <jats:italic>WASF2<\/jats:italic> methylation status.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p><jats:italic>WASF2<\/jats:italic> is overexpressed in HCC and is clinically correlated with its prognosis.\u00a0<jats:italic>WASF2<\/jats:italic> overexpression promoted normal hepatocyte proliferation.\u00a0<jats:italic>WASF2<\/jats:italic> inactivation decreased the viability, growth, proliferation, migration, and invasion of Huh-7 and SNU475 HCC cells by inducing G2\/M phase arrest. This induced cell death and inhibited epithelial\u2013mesenchymal transition, hindering actin polymerization. In addition, <jats:italic>WASF2<\/jats:italic> knockdown using siWASF2 in a xenograft mouse model and a lung metastasis model exerted tumor suppressive effect. There was a negative correlation between <jats:italic>WASF2<\/jats:italic> methylation status and mRNA expression. The methylation pattern of CpG site 2 (\u2212\u2009726\u2009bp), located in the <jats:italic>WASF2<\/jats:italic> promoter, plays an important role in the regulation of WASF2 expression. Furthermore, the cg242579 CpG island in the <jats:italic>WASF2<\/jats:italic> 5\u2032 promoter region was hypomethylated in HCC compared to that in the matched non-tumor samples. Patients with high <jats:italic>WASF2<\/jats:italic> methylation and low <jats:italic>WASF2<\/jats:italic> expression displayed the highest overall survival.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p><jats:italic>WASF2<\/jats:italic> is overexpressed and hypomethylated in HCC and correlates with patient prognosis. <jats:italic>WASF2<\/jats:italic> inactivation exerts anti-tumorigenic effects on HCC cells in vitro and in vivo, suggesting that <jats:italic>WASF2<\/jats:italic> could be a potential therapeutic target for HCC.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13046-022-02365-7","type":"journal-article","created":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T04:45:05Z","timestamp":1651121105000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Hypomethylation-mediated upregulation of the WASF2 promoter region correlates with poor clinical outcomes in hepatocellular carcinoma"],"prefix":"10.1186","volume":"41","author":[{"given":"Hye Ri","family":"Ahn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geum Ok","family":"Baek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moon Gyeong","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ju A","family":"Son","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung Hwan","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae Youn","family":"Cheong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyo Jung","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ho Chul","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung Woo","family":"Eun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6862-1896","authenticated-orcid":false,"given":"Soon Sun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,28]]},"reference":[{"key":"2365_CR1","doi-asserted-by":"publisher","unstructured":"Massarweh NN, El-Serag HB. Epidemiology of hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Cancer Control. 2017;24. https:\/\/doi.org\/10.1177\/1073274817729245.","DOI":"10.1177\/1073274817729245"},{"key":"2365_CR2","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1001\/jamaoncol.2017.3055","volume":"3","author":"T Akinyemiju","year":"2017","unstructured":"Global Burden of Disease Liver Cancer Collaboration, Akinyemiju T, Abera S, Ahmed M, Alam N, Alemayohu MA, et al. The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: results from the global burden of disease study 2015. JAMA Oncol. 2017;3:1683\u201391.","journal-title":"JAMA Oncol"},{"key":"2365_CR3","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.jhep.2020.11.036","volume":"74","author":"S Heinrich","year":"2021","unstructured":"Heinrich S, Craig AJ, Ma L, Heinrich B, Greten TF, Wang XW. Understanding tumour cell heterogeneity and its implication for immunotherapy in liver cancer using single-cell analysis. J Hepatol. 2021;74:700\u201315.","journal-title":"J Hepatol"},{"key":"2365_CR4","doi-asserted-by":"publisher","first-page":"3739","DOI":"10.1073\/pnas.96.7.3739","volume":"96","author":"LM Machesky","year":"1999","unstructured":"Machesky LM, Mullins RD, Higgs HN, Kaiser DA, Blanchoin L, May RC, et al. Scar, a WASp-related protein, activates nucleation of actin filaments by the Arp2\/3 complex. Proc Natl Acad Sci U S A. 1999;96:3739\u201344.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2365_CR5","doi-asserted-by":"publisher","first-page":"3602","DOI":"10.1093\/emboj\/cdg350","volume":"22","author":"C Yan","year":"2003","unstructured":"Yan C, Martinez-Quiles N, Eden S, Shibata T, Takeshima F, Shinkura R, et al. WAVE2 deficiency reveals distinct roles in embryogenesis and Rac-mediated actin-based motility. EMBO J. 2003;22:3602\u201312.","journal-title":"EMBO J"},{"key":"2365_CR6","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1038\/sj.onc.1208177","volume":"24","author":"S Kurisu","year":"2005","unstructured":"Kurisu S, Suetsugu S, Yamazaki D, Yamaguchi H, Takenawa T. Rac-WAVE2 signaling is involved in the invasive and metastatic phenotypes of murine melanoma cells. Oncogene. 2005;24:1309\u201319.","journal-title":"Oncogene."},{"key":"2365_CR7","doi-asserted-by":"publisher","first-page":"5733","DOI":"10.1002\/cam4.1837","volume":"7","author":"K Taniuchi","year":"2018","unstructured":"Taniuchi K, Furihata M, Naganuma S, Saibara T. WAVE2 is associated with poor prognosis in pancreatic cancers and promotes cell motility and invasiveness via binding to ACTN4. Cancer Med. 2018;7:5733\u201351.","journal-title":"Cancer Med"},{"key":"2365_CR8","doi-asserted-by":"publisher","first-page":"5673","DOI":"10.1158\/1078-0432.CCR-06-0022","volume":"12","author":"LY Yang","year":"2006","unstructured":"Yang LY, Tao YM, Ou DP, Wang W, Chang ZG, Wu F. Increased expression of Wiskott-Aldrich syndrome protein family verprolin-homologous protein 2 correlated with poor prognosis of hepatocellular carcinoma. Clin Cancer Res. 2006;12:5673\u20139.","journal-title":"Clin Cancer Res"},{"key":"2365_CR9","doi-asserted-by":"publisher","first-page":"572","DOI":"10.3390\/genes11050572","volume":"11","author":"MA Arkorful","year":"2020","unstructured":"Arkorful MA, Noren Hooten N, Zhang Y, Hewitt AN, Barrientos Sanchez L, Evans MK, et al. MicroRNA-1253 regulation of WASF2 (WAVE2) and its relevance to racial health disparities. Genes. 2020;11:572.","journal-title":"Genes."},{"key":"2365_CR10","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1186\/s12864-015-1847-z","volume":"16","author":"A Koch","year":"2015","unstructured":"Koch A, De Meyer T, Jeschke J, Van Criekinge W. MEXPRESS: visualizing expression, DNA methylation and clinical TCGA data. BMC Genomics. 2015;16:636.","journal-title":"BMC Genomics"},{"key":"2365_CR11","doi-asserted-by":"publisher","first-page":"603","DOI":"10.3892\/br.2015.494","volume":"3","author":"BO Sun","year":"2015","unstructured":"Sun BO, Fang Y, Li Z, Chen Z, Xiang J. Role of cellular cytoskeleton in epithelial-mesenchymal transition process during cancer progression. Biomed Rep. 2015;3:603\u201310.","journal-title":"Biomed Rep"},{"key":"2365_CR12","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/S0955-0674(97)80156-1","volume":"9","author":"N Tapon","year":"1997","unstructured":"Tapon N, Hall A. Rho, Rac and Cdc42 GTPases regulate the organization of the actin cytoskeleton. Curr Opin Cell Biol. 1997;9:86\u201392.","journal-title":"Curr Opin Cell Biol"},{"key":"2365_CR13","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1094\/MPMI-05-14-0155-R","volume":"27","author":"F del Toro","year":"2014","unstructured":"del Toro F, Fern\u00e1ndez FT, Tilsner J, Wright KM, Tenllado F, Chung BN, et al. Potato virus Y HCPro localization at distinct, dynamically related and environment-influenced structures in the cell cytoplasm. Mol Plant-Microbe Interact. 2014;27:1331\u201343.","journal-title":"Mol Plant-Microbe Interact"},{"key":"2365_CR14","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.autrev.2016.01.017","volume":"15","author":"P Zaenker","year":"2016","unstructured":"Zaenker P, Gray ES, Ziman MR. Autoantibody production in cancer\u2014the humoral immune response toward autologous antigens in cancer patients. Autoimmun Rev. 2016;15:477\u201383.","journal-title":"Autoimmun Rev"},{"key":"2365_CR15","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3233\/CBM-2009-0138","volume":"6","author":"SP Dudas","year":"2010","unstructured":"Dudas SP, Chatterjee M, Tainsky MA. Usage of cancer associated autoantibodies in the detection of disease. Cancer Biomark. 2010;6:257\u201370.","journal-title":"Cancer Biomark"},{"key":"2365_CR16","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/35047107","volume":"408","author":"H Miki","year":"2000","unstructured":"Miki H, Yamaguchi H, Suetsugu S, Takenawa T. IRSp53 is an essential intermediate between Rac and WAVE in the regulation of membrane ruffling. Nature. 2000;408:732\u20135.","journal-title":"Nature."},{"key":"2365_CR17","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/nature01770","volume":"424","author":"D Yamazaki","year":"2003","unstructured":"Yamazaki D, Suetsugu S, Miki H, Kataoka Y, Nishikawa S, Fujiwara T, et al. WAVE2 is required for directed cell migration and cardiovascular development. Nature. 2003;424:452\u20136.","journal-title":"Nature."},{"key":"2365_CR18","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/modpathol.3800741","volume":"20","author":"K Iwaya","year":"2007","unstructured":"Iwaya K, Norio K, Mukai K. Coexpression of Arp2 and WAVE2 predicts poor outcome in invasive breast carcinoma. Mod Pathol. 2007a;20:339\u201343.","journal-title":"Mod Pathol"},{"key":"2365_CR19","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1111\/j.1349-7006.2007.00488.x","volume":"98","author":"K Iwaya","year":"2007","unstructured":"Iwaya K, Oikawa K, Semba S, Tsuchiya B, Mukai Y, Otsubo T, et al. Correlation between liver metastasis of the colocalization of actin-related protein 2 and 3 complex and WAVE2 in colorectal carcinoma. Cancer Sci. 2007b;98:992\u20139.","journal-title":"Cancer Sci"},{"key":"2365_CR20","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s10059-012-2285-2","volume":"33","author":"SJ Park","year":"2012","unstructured":"Park SJ, Kim YT, Jeon YJ. Antioxidant dieckol downregulates the Rac1\/ROS signaling pathway and inhibits Wiskott-Aldrich syndrome protein (WASP)-family verprolin-homologous protein 2 (WAVE2)-mediated invasive migration of B16 mouse melanoma cells. Mol Cells. 2012;33:363\u20139.","journal-title":"Mol Cells"},{"key":"2365_CR21","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/nrc.2017.118","volume":"18","author":"T Brabletz","year":"2018","unstructured":"Brabletz T, Kalluri R, Nieto MA, Weinberg RA. EMT in cancer. Nat Rev Cancer. 2018;18:128\u201334.","journal-title":"Nat Rev Cancer"},{"key":"2365_CR22","doi-asserted-by":"publisher","first-page":"e1675","DOI":"10.1038\/cddis.2015.20","volume":"6","author":"V Labi","year":"2015","unstructured":"Labi V, Erlacher M. How cell death shapes cancer. Cell Death Dis. 2015;6:e1675.","journal-title":"Cell Death Dis"},{"key":"2365_CR23","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/nrc.2016.138","volume":"17","author":"T Otto","year":"2017","unstructured":"Otto T, Sicinski P. Cell cycle proteins as promising targets in cancer therapy. Nat Rev Cancer. 2017;17:93\u2013115.","journal-title":"Nat Rev Cancer"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-022-02365-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-022-02365-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-022-02365-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T04:48:04Z","timestamp":1651121284000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-022-02365-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,28]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2365"],"URL":"https:\/\/doi.org\/10.1186\/s13046-022-02365-7","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,28]]},"assertion":[{"value":"9 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experiments were performed according to the Declaration of Helsinki and the study was approved by the Institutional Review Board of Ajou University Hospital (AJIRB-BMR-KSP-16-365 and AJIRB-BMR-SMP-17-189). Anonymous serum samples and clinical data were provided by the Ajou Human Bio-Resource Bank, and the need for informed consent was waived. All animals were maintained according to the Guide for the Care and Use of Laboratory Animals. The experiments were approved by the Ethics Committee for Laboratory Animal Research Center of Ajou University Medical Center (IACUC-2020-0007).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"158"}}